Related Experiment Video
Updated: Aug 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-lowering therapy in high-risk persons
1Department of Medicine, Cardiology Division, New York Medical College, Valhalla, NY 10595, USA. WSAronow@aol.com
Insights
Statins significantly lower mortality and major cardiovascular events in high-risk individuals with hypercholesterolemia. This lipid-lowering therapy is effective across diverse demographics and initial lipid levels, supporting updated clinical guidelines.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypercholesterolemia poses a significant risk for cardiovascular events.
- Lipid-lowering therapy is a cornerstone in managing cardiovascular risk.
Purpose of the Study:
- To summarize evidence on the efficacy of statins in reducing cardiovascular outcomes.
- To inform clinical practice and guideline development for hypercholesterolemia management.
Main Methods:
- Review of randomized, double-blind, placebo-controlled studies.
- Inclusion of observational studies evaluating statin use.
- Analysis of data from landmark trials like the Heart Protection Study.
Main Results:
- Statins demonstrated a significant reduction in mortality.
- Major cardiovascular events were substantially decreased in high-risk populations.
- Benefits were observed irrespective of baseline lipid levels, age, or gender.
Conclusions:
- Statins are highly effective in reducing cardiovascular morbidity and mortality in high-risk individuals.
- Lipid-lowering therapy with statins provides a robust evidence base for current guidelines.
- The findings support the widespread use of statins for primary and secondary prevention in appropriate patient groups.
Abstract:
Randomized, double-blind, placebo-controlled studies and observational studies have demonstrated that statins reduce mortality and major cardiovascular events in high-risk persons with hypercholesterolemia. The Heart Protection Study showed that statins reduced mortality and major cardiovascular events in high-risk persons, regardless of the initial level of serum lipids, age, or gender. Lipid-lowering therapy reduces cardiovascular morbidity and mortality in high-risk persons, forming the basis for the updated National Cholesterol Education Program (NCEP) III guidelines.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Hypertension IV: Drug Therapy and Lifestyle Modifications